Harvard Bioscience (HBIO) Net Cash Flow Growth (5y) (2015 - 2026)
Harvard Bioscience (HBIO) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.57 Bn | 121.35 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 45.01 Bn | 44.20 Bn | 2.15 Bn |
| 3 | Alcon | 33.11 Bn | 31.45 Bn | 1.53 Bn |
| 4 | Medline | 32.83 Bn | 30.60 Bn | 1.84 Bn |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.09 Bn | 22.65 Bn | 329.20 Mn |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn |
| 9 | Align Technology | 12.11 Bn | 11.05 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 27.33 Mn | 20.23 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.70% |
| Dec 31, 2025 | -20.53% |
| Sep 30, 2025 | -54.40% |
| Jun 30, 2025 | 19.07% |
| Mar 31, 2025 | 19.63% |
| Dec 31, 2024 | -15.70% |
| Sep 30, 2024 | -41.15% |
| Jun 30, 2024 | -9.18% |
| Mar 31, 2024 | 15.32% |
| Dec 31, 2023 | -20.52% |
| Sep 30, 2023 | 3.66% |
| Jun 30, 2023 | 105.67% |
| Mar 31, 2023 | -9.80% |
| Dec 31, 2022 | 28.94% |
| Sep 30, 2022 | -12.93% |
| Jun 30, 2022 | -55.29% |
| Mar 31, 2022 | -16.40% |
| Dec 31, 2021 | 10.80% |
| Sep 30, 2021 | -18.62% |
| Jun 30, 2021 | 21.38% |